[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2021,71(3):209-249.
[2] STOLNICU S,BARSAN I,HOANG L,et al.International endocervical adenocarcinoma criteria and classification (IECC):A new pathogenetic classification for invasive adenocarcinomas of the endocervix [J].Am J Surg Pathol,2018,42(2):214-226.
[3] WHO classification of tumours editorial board.WHO classification of tumours.Female genital tumours [M].5th ed.Lyon:IARC Press,2020:335-337.
[4] 闵锐,李楠,曹锦涛,等.子宫颈中肾管腺癌1例并文献复习[J].临床与实验病理学杂志,2022,38(4):474-476.
MIN Rui,LI Nan,CAO Jintao,et al.Cervical mesonephric adenocarcinoma:a case report and literature review [J].Chinese Journal of Clinical and Experimental Pathology,2022,38(4):474-476.
[5] 张惠斌,林建松,傅建辉,等.子宫具有中肾形态特征的腺癌4例临床病理分析[J].临床与实验病理学杂志,2023,39(3):356-359.
ZHANG Huibin,LIN Jiansong,FU Jianhui,et al.Cervical mesonephric.adenocarcinoma:a clinicopathological analysis of 9 cases and review of the literature [J].Chinese Journal of Clinical and Experimental Pathology,2023,39(3):356-359.
[6] WONG RW,NG JHY,HAN KC,et al.Cervical carcinomas with serous-like papillary and micropapillary components:illustrating the heterogeneity of primary cervical carcinomas [J].Mod Pathol,2021,34(1):207-221.
[7] CARLETON C,HOANG L,SAH S,et al.A Detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas [J].Am J Surg Pathol,2016,40(5):636-644.
[8] WADA T,OHISHI Y,KAKU T,et al.Endocervical adenocarcinoma with morphologic features of both usual and gastric types:Clinicopathologic and immunohistochemical analyses and high-risk HPV detection by in situ hybridization [J].Am J Surg Pathol,2017,41(5):696-705.
[9] LU S,SHEN D,ZHAO Y,et al.Primary endocervical gastric-type adenocarcinoma:a clinicopathologic and immunohistochemical analysis of 23 cases [J].Diagn Pathol,2019,14(1):72.
[10] PARK KJ,KIYOKAWA T,SOSLOW RA,et al.Unusual endocervical adenocarcinomas:an immunohistochemical analysis with molecular detection of human papillomavirus [J].Am J Surg Pathol,2011,35(5):633-646.
[11] STOLNICU S,BARSAN I,HOANG L,et al.Diagnostic algorithmic proposal based on comprehensive immunohistochemical evaluation of 297 invasive endocervical adenocarcinomas [J].Am J Surg Pathol,2018,42(8):989-1000.
[12] KOJIMA A,MIKAMI Y,SUDO T,et al.Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix [J].Am J Surg Pathol,2007,31(5):664-672.
[13] KAWAKAMI F,MIKAMI Y,KOJIMA A,et al.Diagnostic reproducibility in gastric-type mucinous adenocarcinoma of the uterine cervix:validation of novel diagnostic criteria [J].Histopathology,2010,56(4):551-553.
[14] HODGSON A,PARRA-HERRAN C,MIRKOVIC J.Immunohistochemical expression of HIK1083 and MUC6 in endometrial carcinomas [J].Histopathology,2019,75(4):552-558.
[15] KONDO T,HASHI A,MURATA SI,et al.Gastric mucin is expressed in a subset of endocervical tunnel clusters:type A tunnel clusters of gastric phenotype [J].Histopathology,2007,50(7):843-850.
[16] LIMA PC,TEIXEIRA J,AIRES GN,et al.Endocervical gastric-type adenocarcinoma,an unrelated HPV tumour:difficulties in screening and diagnosis [J].BMJ Case Rep,2017,32(3):1-4.
[17] MIKAMI Y,MCCLUGGAGE WG.Endocervical glandular lesions exhibiting gastric differentiation:an emerging spectrum of benign,premalignant,and malignant lesions [J].Adv Anat Pathol,2013,20(4):227-237.
[18] EHMANN S,SASSINE D,STRAUBHAR AM,et al.Gastric-type adenocarcinoma of the cervix:Clinical outcomes and genomic drivers [J].Gynecol Oncol,2022,167(3):458-466.
[19] KURAGAKI C,ENOMOTO T,UENO Y,et al.Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix [J].Lab Invest,2003,83(1):35-45.
[20] GARG S,NAGARIA TS,CLARKE B,et al.Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing [J].Mod Pathol,2019,32(12):1823-1833.
[21] LIU Y,XU Y,JIANG W,et al.Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer [J].Mol Ther Methods Clin Dev,2021,21:492-506.
[22] BOYD J,TAKAHASHI H,WAGGONER SE,et al.Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero [J].Cancer,1996,77(3):507-513.
[23] GIANNELLA L,DI GIUSEPPE J,DELLI CARPINI G,et al.HPV-negative adenocarcinomas of the uterine cervix:From molecular characterization to clinical implications [J].Int J Mol Sci,2022,23(23):1-20.